Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

• Status: Completed
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Miami
• Collaborator: Graceway Pharmaceuticals, LLC
• Treatments: Imiquimod

Criteria

Inclusion Criteria:

• 2 tattoos no larger than 25cm2, professionally made, with approximately the same age, containing blue/black ink.

Exclusion Criteria:

• Hypersensitivity to imiquimod

• Current sun tan

• Use of vitamin E, non-steroid anti-inflammatory drugs, coumadin or aspirin for the past 10 days

• Amateur tattoos

• Pregnancy

• Breast-feeding status

• Immunosuppression

• Auto-immune diseases.